Clinical Trials in Illinois

Showing 5121-5140 of 14,943 trials

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

NCT03421353

This is a phase Ib/II, open-label multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 plus durvalumab alone or in combination with chemotherapy in patients with advanced, solid tumours and subsequently in patients with non-small-cell lung cancer (NSCLC)

Advanced Solid Tumours

AstraZeneca76 participantsStarted Feb 2018

Lafayette, Indiana, United States • Oklahoma City, Oklahoma, United States • Nashville, Tennessee, United States +3 more locations

TERMINATEDPhase 1111 miles

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

NCT05251727

To evaluate the safety and tolerability of ART-123 in patients with metastatic colorectal cancer who receive oxaliplatin-containing chemotherapy and bevacizumab

Chemotherapy-induced Peripheral Neuropathy

Veloxis Pharmaceuticals77 participantsStarted Mar 2022

Beverly Hills, California, United States • Los Angeles, California, United States • Norwich, Connecticut, United States +29 more locations

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Find Trials by Condition in Illinois

Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

CardioFocus HeartLight Post-Approval Study

Physiologic Pacing Registry

Situation Awareness Incorporating Multidisciplinary Teams Reduce Arrests In the Pediatric ICU

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Study of OMNI System in OAG (GEMINI)

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Comparing Two Models of Well-Child Care for Black Families

MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)

Cefadroxil 500 mg Capsules Under Fasting Conditions

Pilot Randomized Trial With Flecainide in ARVC Patients

Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping